Skip to content
Triangle logo TriangleGet started
← Childhood Acute Myeloid Leukemia

HEALTH PROFESSIONAL · SOURCE READING

Treatment of recurrent AML

Source: Childhood Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 15, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Recurrent or Refractory Childhood AML / Recurrent Childhood AML

Treatment options for children with recurrent AML may include the following:

Chemotherapy.

Source links and citations

Immunotherapeutic approaches.

Source links and citations

Targeted therapy (FLT3 inhibitors).

Source links and citations

HSCT.

Source links and citations

Second transplant after relapse following a first transplant.

Source links and citations

Continue within this section

Chemotherapy →Immunotherapeutic approaches →Targeted therapy (FLT3 inhibitors) →HSCT →Second transplant after relapse following a first transplant →

Preserved source evidence · Not medical advice